Advertisement
Screener

NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

NATURAL ALTERNATIVES INTERNATIONAL INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-19.

Financial Statements › Shareholders' Equity

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-05-19

  • NATURAL ALTERNATIVES INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares.
  • NATURAL ALTERNATIVES INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
  • NATURAL ALTERNATIVES INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
  • NATURAL ALTERNATIVES INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 0.00 shares.
  • NATURAL ALTERNATIVES INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2020 was 0.00 shares.
  • NATURAL ALTERNATIVES INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2019 was 0.00 shares.
  • NATURAL ALTERNATIVES INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2018 was 0.00 shares.
  • NATURAL ALTERNATIVES INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2017 was 0.00 shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month
2026-03-310.00 shares
10-Q · filed 2026-05-19
0.00 shares
derived: sum of 2 quarters · filed 2026-05-19
0.00 shares
10-Q · filed 2026-05-19
2025-12-310.00 shares
10-Q · filed 2026-02-13
0.00 shares
10-Q · filed 2026-02-13
2025-09-300.00 shares
10-Q · filed 2025-11-12
2025-03-310.00 shares
10-Q · filed 2026-05-19
0.00 shares
derived: sum of 2 quarters · filed 2026-05-19
0.00 shares
10-Q · filed 2026-05-19
2024-12-310.00 shares
10-Q · filed 2026-02-13
0.00 shares
10-Q · filed 2026-02-13
2024-09-300.00 shares
10-Q · filed 2025-11-12
2024-03-310.00 shares
10-Q · filed 2025-05-14
0.00 shares
derived: sum of 2 quarters · filed 2025-05-14
0.00 shares
10-Q · filed 2025-05-14
2023-12-310.00 shares
10-Q · filed 2025-02-14
0.00 shares
10-Q · filed 2025-02-14
2023-09-300.00 shares
10-Q · filed 2024-11-13
2023-03-310.00 shares
10-Q · filed 2024-05-14
0.00 shares
derived: sum of 2 quarters · filed 2024-05-14
0.00 shares
10-Q · filed 2024-05-14
2022-12-310.00 shares
10-Q · filed 2023-02-08
0.00 shares
10-Q · filed 2023-02-08
2022-09-300.00 shares
10-Q · filed 2023-11-09
2022-03-310.00 shares
10-Q · filed 2023-05-15
0.00 shares
derived: sum of 2 quarters · filed 2023-05-15
0.00 shares
10-Q · filed 2023-05-15
2021-12-310.00 shares
10-Q · filed 2023-02-08
0.00 shares
10-Q · filed 2023-02-08
2021-09-300.00 shares
10-Q · filed 2021-11-09
2021-03-310.00 shares
10-Q · filed 2022-05-13
0.00 shares
derived: sum of 2 quarters · filed 2022-05-13
0.00 shares
10-Q · filed 2022-05-13
0.00 shares
derived: sum of 4 quarters · filed 2022-05-13
2020-12-310.00 shares
10-Q · filed 2022-02-09
0.00 shares
10-Q · filed 2022-02-09
0.00 shares
derived: sum of 3 quarters · filed 2022-02-09
0.00 shares
derived: sum of 4 quarters · filed 2022-02-09
2020-09-300.00 shares
10-Q · filed 2021-11-09
0.00 shares
derived: sum of 2 quarters · filed 2021-11-09
0.00 shares
derived: sum of 3 quarters · filed 2021-11-09
0.00 shares
derived: sum of 4 quarters · filed 2021-11-09
2020-06-300.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-21
0.00 shares
derived: sum of 2 quarters · filed 2020-09-21
0.00 shares
derived: sum of 3 quarters · filed 2020-09-21
0.00 shares
10-K · filed 2020-09-21
2020-03-310.00 shares
10-Q · filed 2020-05-14
0.00 shares
derived: sum of 2 quarters · filed 2020-05-14
0.00 shares
10-Q · filed 2020-05-14
0.00 shares
derived: sum of 4 quarters · filed 2020-11-10
2019-12-310.00 shares
10-Q · filed 2020-02-11
0.00 shares
10-Q · filed 2020-02-11
0.00 shares
derived: sum of 3 quarters · filed 2020-11-10
0.00 shares
derived: sum of 4 quarters · filed 2020-11-10
2019-09-300.00 shares
10-Q · filed 2020-11-10
0.00 shares
derived: sum of 2 quarters · filed 2020-11-10
0.00 shares
derived: sum of 3 quarters · filed 2020-11-10
0.00 shares
derived: sum of 4 quarters · filed 2020-11-10
2019-06-300.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-21
0.00 shares
derived: sum of 2 quarters · filed 2020-09-21
0.00 shares
derived: sum of 3 quarters · filed 2020-09-21
0.00 shares
10-K · filed 2020-09-21
2019-03-310.00 shares
10-Q · filed 2020-05-14
0.00 shares
derived: sum of 2 quarters · filed 2020-05-14
0.00 shares
10-Q · filed 2020-05-14
0.00 shares
derived: sum of 4 quarters · filed 2020-05-14
2018-12-310.00 shares
10-Q · filed 2020-02-11
0.00 shares
10-Q · filed 2020-02-11
0.00 shares
derived: sum of 3 quarters · filed 2020-02-11
0.00 shares
derived: sum of 4 quarters · filed 2020-02-11
2018-09-300.00 shares
10-Q · filed 2019-11-14
0.00 shares
derived: sum of 2 quarters · filed 2019-11-14
0.00 shares
derived: sum of 3 quarters · filed 2019-11-14
0.00 shares
derived: sum of 4 quarters · filed 2019-11-14
2018-06-300.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-24
0.00 shares
derived: sum of 2 quarters · filed 2019-09-24
0.00 shares
derived: sum of 3 quarters · filed 2019-09-24
0.00 shares
10-K · filed 2019-09-24
2018-03-310.00 shares
10-Q · filed 2019-05-09
0.00 shares
derived: sum of 2 quarters · filed 2019-05-09
0.00 shares
10-Q · filed 2019-05-09
0.00 shares
derived: sum of 4 quarters · filed 2019-05-09
2017-12-310.00 shares
10-Q · filed 2019-02-12
0.00 shares
10-Q · filed 2019-02-12
0.00 shares
derived: sum of 3 quarters · filed 2019-02-12
0.00 shares
derived: sum of 4 quarters · filed 2019-02-12
2017-09-300.00 shares
10-Q · filed 2018-11-13
0.00 shares
derived: sum of 2 quarters · filed 2018-11-13
0.00 shares
derived: sum of 3 quarters · filed 2018-11-13
0.00 shares
derived: sum of 4 quarters · filed 2018-11-13
2017-06-300.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-19
0.00 shares
derived: sum of 2 quarters · filed 2018-09-19
0.00 shares
derived: sum of 3 quarters · filed 2018-09-19
0.00 shares
10-K · filed 2018-09-19
2017-03-310.00 shares
10-Q · filed 2018-05-14
0.00 shares
derived: sum of 2 quarters · filed 2018-05-14
0.00 shares
10-Q · filed 2018-05-14
2016-12-310.00 shares
10-Q · filed 2018-02-13
0.00 shares
10-Q · filed 2018-02-13
2016-09-300.00 shares
10-Q · filed 2017-11-13
2016-06-300.00 shares
10-K · filed 2017-09-18
2015-06-300.00 shares
10-K · filed 2016-09-19
2014-06-300.00 shares
10-K · filed 2015-09-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
MANNATECH INC (MTEX)United States$0.014B
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Canopy Growth Corp (CGC)$0.395B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87